Tc. Sarich et al., Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor, J PHARM EXP, 289(2), 1999, pp. 695-702
Citations number
40
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Isoniazid (INH), a widely used drug in the prophylaxis and treatment of tub
erculosis, is associated with a 1 to 2% risk of severe and potentially fata
l hepatotoxicity. There is evidence that the INH metabolite hydrazine plays
an important role in the mechanism of this toxicity. Metabolism of INH lea
ds to the production of hydrazine via both direct and indirect pathways. In
both cases, the activity of an INH amidase is required to hydrolyze an ami
de bond. In the present study, using a model of INH-induced hepatotoxicity
in rabbits, pretreatment of rabbits with the amidase inhibitor bis-p-nitrop
henyl phosphate 30 min before injection of INH inhibited the formation of I
NH-derived hydrazine and decreased measures of hepatocellular damage, hepat
ic triglyceride accumulation, and hypertriglyceridemia. Bis-p-nitrophenyl p
hosphate also potently inhibited the production of hydrazine from INH in in
vitro microsomal incubations (IC50 2 mu M). Although hepatic glutathione s
tores are decreased, they are not depleted in animals with INH-induced hepa
totoxicity. Significant effects on hepatic microsomal cytochrome P-450 1A1/
2 and cytochrome P-450 2E1 activities suggest that these isozymes may be in
volved in the mechanism of the toxicity. In conclusion, this study demonstr
ates the importance of amidase activity in this rabbit model of hepatotoxic
ity and provides additional evidence in support of the role of hydrazine in
the mechanism of INH-induced hepatotoxicity.